// App-Quantinova.ai

PB0993 : Data Mining: An Innovative Approach to Optimise Post-Hoc Analyses of Large Trial Data Sets into Clinically Relevant Results

Researchers

Presenter

  • P. Chowdary

Principal Investigators

  • S. Benchikh El Fegoun

  • M.S. Geybels

  • A. Tiede

Medical Centers

  • Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free NHS Trust, London, United Kingdom

  • Novo Nordisk Health Care A/S, Zurich, Switzerland

  • Novo Nordisk A/S, Bagsværd, Denmark

  • Hannover Medical School - Department of Haematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover,

Locations

  • United Kingdom

  • Switzerland

  • Denmark

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A